Table 1.
Risk factor | Rheumatology/orthopedy, n = 207 | Oncology, n = 209 | Psychosomatics, n = 224 | Cardiology/orthopedy, n = 202 | Overall, n = 842 |
---|---|---|---|---|---|
MRSA carrier status | 0.5% | 1.4% | 0.9% | 1.5% | 1.1% |
Previous history of MRSA | 2.9% | 6.2% | 2.2% | 5.9% | 4.3% |
Stay in risk region | 5.3% | 5.7% | 8.9% | 6.4% | 6.7% |
Stay in hospital for > 3 days during the past months | 50.2% | 72.2% | 25.4% | 57.4% | 50.8% |
Contact to person with carrier status | 0.0% | 1.0% | 0.4% | 0.5% | 0.5% |
Dependence on renal dialysis | 0.0% | 1.0% | 0.4% | 1.5% | 0.7% |
Contact with MRSA at work setting | 10.6% | 5.3% | 12.1% | 4.0% | 8.1% |
Chronical skin lesions | 2.4% | 2.4% | 5.8% | 2.5% | 3.3% |
Chronical care dependency | 0.5% | 5.3% | 0.0% | 1.5% | 1.8% |
Antibiotic treatment within 6 months | 17.9% | 36.8% | 16.5% | 21.3% | 23.0% |
Catheter or other medical tools injuring the skin barrier | 1.9% | 3.3% | 0.0% | 2.0% | 1.8% |
Screening recommended | 57.0% | 76.6% | 41.5% | 61.4% | 58.8% |
Current immune suppression | 26.6% | 11.0% | 0.9% | 3.0% | 10.2% |
Immune suppression within 12 months | 28.0% | 30.6% | 2.7% | 6.9% | 16.9% |
Surgery within 12 months | 37.2% | 76.6% | 15.2% | 46.5% | 43.3% |
Contact to persons working in direct patient care | 29.0% | 45.0% | 33.0% | 29.7% | 34.2% |
Pet within 12 months | 39.1% | 28.2% | 52.2% | 44.6% | 41.2% |